# Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery

> **NCT02046135** · PHASE2 · TERMINATED · sponsor: **Northwell Health** · enrollment: 51 (actual)

## Conditions studied

- Acute Kidney Injury
- Congenital Heart Disease

## Interventions

- **DRUG:** Sodium Bicarbonate
- **DRUG:** Sodium Chloride

## Key facts

- **NCT ID:** NCT02046135
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2017-06
- **Final completion:** 2017-07-22
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Statistical analysis at interim analysis determined futility in continuing.
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02046135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02046135, "Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02046135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*